← Open Payments lookup

JAMIE ROMERO: Open Payments

NPI 1225783848 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$466 in 20 payments from 9 companies in 2025. Trend: 2023 $285 · 2024 $368 · 2025 $466

Food & beverage: $466
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.4$83
Novartis Pharmaceuticals Corporation3$70
Otsuka America Pharmaceutical, Inc.3$66
Calliditas Therapeutics US Inc.2$63
AKEBIA THERAPEUTICS INC2$54
Ardelyx, Inc.2$43
AstraZeneca Pharmaceuticals LP2$39
Novo Nordisk Inc1$24
Vifor Pharma, Inc.1$23

Products named: Kerendia, Vanrafia, TARPEYO, Vafseo, JYNARQUE, IBSRELA, Wegovy, Veltassa.

Industry payments across MD — which companies pay providers there.